 Cathy Bradley
Concepts (476)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 62 | 2024 | 2147 | 10.810 |
Why?
| | Employment | 37 | 2024 | 136 | 10.230 |
Why?
| | Medicaid | 37 | 2023 | 419 | 8.830 |
Why?
| | Breast Neoplasms | 47 | 2023 | 1883 | 6.270 |
Why?
| | Cancer Survivors | 13 | 2023 | 201 | 4.920 |
Why?
| | Insurance Coverage | 20 | 2023 | 207 | 4.500 |
Why?
| | Insurance, Health | 19 | 2023 | 247 | 4.190 |
Why?
| | Medicare | 34 | 2023 | 668 | 3.850 |
Why?
| | SEER Program | 21 | 2022 | 202 | 3.350 |
Why?
| | Poverty | 13 | 2022 | 446 | 3.290 |
Why?
| | Healthcare Disparities | 14 | 2020 | 494 | 2.950 |
Why?
| | Cost of Illness | 13 | 2022 | 253 | 2.920 |
Why?
| | Colorectal Neoplasms | 15 | 2022 | 630 | 2.780 |
Why?
| | Medically Uninsured | 12 | 2020 | 125 | 2.780 |
Why?
| | Uterine Cervical Neoplasms | 7 | 2020 | 214 | 2.640 |
Why?
| | United States | 89 | 2023 | 12385 | 2.540 |
Why?
| | Early Detection of Cancer | 9 | 2022 | 356 | 2.380 |
Why?
| | Survivors | 16 | 2022 | 408 | 2.310 |
Why?
| | Registries | 31 | 2023 | 1789 | 2.220 |
Why?
| | Health Services Accessibility | 16 | 2023 | 774 | 2.190 |
Why?
| | Health Benefit Plans, Employee | 5 | 2022 | 20 | 2.070 |
Why?
| | Humans | 186 | 2024 | 117083 | 1.890 |
Why?
| | Caregivers | 6 | 2023 | 717 | 1.880 |
Why?
| | Health Care Costs | 13 | 2022 | 384 | 1.840 |
Why?
| | Survivorship | 4 | 2022 | 38 | 1.840 |
Why?
| | Health Care Reform | 4 | 2021 | 92 | 1.650 |
Why?
| | Antineoplastic Agents | 8 | 2020 | 1941 | 1.610 |
Why?
| | Medical Oncology | 5 | 2023 | 231 | 1.570 |
Why?
| | Drug Costs | 3 | 2023 | 90 | 1.550 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 5 | 2020 | 975 | 1.510 |
Why?
| | Colonic Neoplasms | 5 | 2016 | 223 | 1.440 |
Why?
| | Mental Health | 4 | 2023 | 565 | 1.440 |
Why?
| | Aged | 69 | 2023 | 19367 | 1.420 |
Why?
| | Female | 118 | 2023 | 60665 | 1.410 |
Why?
| | Socioeconomic Factors | 20 | 2022 | 1106 | 1.360 |
Why?
| | Research | 6 | 2022 | 402 | 1.330 |
Why?
| | Policy | 4 | 2024 | 138 | 1.330 |
Why?
| | Michigan | 24 | 2015 | 95 | 1.320 |
Why?
| | Middle Aged | 69 | 2023 | 27183 | 1.290 |
Why?
| | Lung Neoplasms | 10 | 2020 | 2222 | 1.280 |
Why?
| | Prostatic Neoplasms | 10 | 2022 | 936 | 1.240 |
Why?
| | Prescription Drugs | 2 | 2023 | 112 | 1.240 |
Why?
| | Neoplasm Staging | 17 | 2022 | 1207 | 1.230 |
Why?
| | Health Status Disparities | 2 | 2023 | 209 | 1.190 |
Why?
| | Income | 7 | 2023 | 171 | 1.190 |
Why?
| | Health Status | 10 | 2013 | 726 | 1.180 |
Why?
| | Medical Record Linkage | 2 | 2021 | 55 | 1.120 |
Why?
| | Aged, 80 and over | 35 | 2020 | 6460 | 1.080 |
Why?
| | Papanicolaou Test | 2 | 2017 | 39 | 1.080 |
Why?
| | Male | 86 | 2022 | 56694 | 1.070 |
Why?
| | Primary Health Care | 6 | 2023 | 1508 | 1.060 |
Why?
| | Motivation | 2 | 2020 | 498 | 1.030 |
Why?
| | Patient Acceptance of Health Care | 4 | 2018 | 678 | 1.000 |
Why?
| | Adult | 60 | 2023 | 31009 | 1.000 |
Why?
| | Efficiency | 6 | 2016 | 87 | 1.000 |
Why?
| | Safety-net Providers | 3 | 2017 | 94 | 0.990 |
Why?
| | Comorbidity | 12 | 2019 | 1487 | 0.910 |
Why?
| | Eligibility Determination | 5 | 2018 | 61 | 0.910 |
Why?
| | Mass Screening | 10 | 2022 | 1035 | 0.910 |
Why?
| | Colonoscopy | 4 | 2019 | 211 | 0.880 |
Why?
| | Health Expenditures | 8 | 2023 | 174 | 0.870 |
Why?
| | Return to Work | 4 | 2022 | 21 | 0.850 |
Why?
| | Absenteeism | 4 | 2013 | 38 | 0.840 |
Why?
| | Virginia | 7 | 2018 | 52 | 0.810 |
Why?
| | Quality of Life | 5 | 2019 | 2375 | 0.810 |
Why?
| | Workplace | 4 | 2021 | 224 | 0.790 |
Why?
| | Health Equity | 1 | 2022 | 56 | 0.780 |
Why?
| | Cancer Care Facilities | 3 | 2023 | 33 | 0.740 |
Why?
| | Medication Adherence | 2 | 2023 | 555 | 0.740 |
Why?
| | Perioperative Care | 1 | 2021 | 129 | 0.720 |
Why?
| | Cost Sharing | 1 | 2020 | 14 | 0.720 |
Why?
| | Models, Economic | 2 | 2011 | 48 | 0.710 |
Why?
| | Information Dissemination | 1 | 2022 | 193 | 0.700 |
Why?
| | Chemotherapy, Adjuvant | 7 | 2023 | 343 | 0.670 |
Why?
| | Preventive Health Services | 5 | 2023 | 134 | 0.660 |
Why?
| | Mammography | 3 | 2014 | 121 | 0.660 |
Why?
| | Health Planning Guidelines | 1 | 2018 | 25 | 0.650 |
Why?
| | Health Facilities | 1 | 2019 | 71 | 0.650 |
Why?
| | Spouses | 3 | 2017 | 90 | 0.640 |
Why?
| | Quality Indicators, Health Care | 1 | 2020 | 287 | 0.620 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 294 | 0.620 |
Why?
| | Young Adult | 22 | 2022 | 10680 | 0.610 |
Why?
| | Survival Analysis | 10 | 2019 | 1240 | 0.610 |
Why?
| | Retirement | 4 | 2022 | 27 | 0.600 |
Why?
| | Reimbursement, Incentive | 1 | 2017 | 36 | 0.590 |
Why?
| | Job Satisfaction | 3 | 2013 | 168 | 0.570 |
Why?
| | Healthy People Programs | 1 | 2016 | 8 | 0.560 |
Why?
| | Occupational Health Services | 2 | 2016 | 30 | 0.560 |
Why?
| | Length of Stay | 6 | 2012 | 989 | 0.560 |
Why?
| | Bevacizumab | 1 | 2017 | 119 | 0.550 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2023 | 159 | 0.550 |
Why?
| | Logistic Models | 13 | 2023 | 1877 | 0.550 |
Why?
| | Chronic Pain | 1 | 2019 | 208 | 0.540 |
Why?
| | Outpatients | 1 | 2019 | 327 | 0.540 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 535 | 0.540 |
Why?
| | Job Description | 2 | 2013 | 10 | 0.540 |
Why?
| | Massachusetts | 4 | 2021 | 139 | 0.530 |
Why?
| | Rectal Neoplasms | 1 | 2016 | 121 | 0.510 |
Why?
| | Nursing Homes | 4 | 2013 | 131 | 0.510 |
Why?
| | Fee-for-Service Plans | 4 | 2023 | 78 | 0.490 |
Why?
| | State Government | 3 | 2014 | 41 | 0.490 |
Why?
| | Vaginal Smears | 1 | 2014 | 48 | 0.490 |
Why?
| | Longitudinal Studies | 10 | 2022 | 2481 | 0.470 |
Why?
| | Mouth Neoplasms | 3 | 2019 | 79 | 0.470 |
Why?
| | Health Personnel | 3 | 2022 | 575 | 0.460 |
Why?
| | Emergency Treatment | 1 | 2015 | 111 | 0.460 |
Why?
| | General Practice | 1 | 2014 | 27 | 0.460 |
Why?
| | Health Services Research | 4 | 2010 | 375 | 0.460 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 1374 | 0.460 |
Why?
| | Sick Leave | 2 | 2019 | 12 | 0.450 |
Why?
| | Delivery of Health Care | 5 | 2024 | 851 | 0.450 |
Why?
| | Databases, Factual | 7 | 2021 | 1168 | 0.440 |
Why?
| | Behavioral Risk Factor Surveillance System | 4 | 2017 | 44 | 0.430 |
Why?
| | Sickness Impact Profile | 1 | 2013 | 50 | 0.430 |
Why?
| | Cost-Benefit Analysis | 8 | 2017 | 544 | 0.430 |
Why?
| | Insurance Claim Review | 2 | 2010 | 66 | 0.420 |
Why?
| | Homes for the Aged | 2 | 2013 | 19 | 0.420 |
Why?
| | Marital Status | 3 | 2007 | 43 | 0.420 |
Why?
| | Survival Rate | 7 | 2020 | 1679 | 0.420 |
Why?
| | Value of Life | 2 | 2008 | 19 | 0.410 |
Why?
| | Work | 3 | 2010 | 16 | 0.410 |
Why?
| | Age Factors | 11 | 2022 | 2951 | 0.410 |
Why?
| | Quality Improvement | 2 | 2018 | 956 | 0.400 |
Why?
| | Cross-Sectional Studies | 11 | 2023 | 4510 | 0.400 |
Why?
| | Neoplasm Metastasis | 3 | 2020 | 534 | 0.400 |
Why?
| | Risk Factors | 13 | 2021 | 8874 | 0.390 |
Why?
| | Periodicals as Topic | 2 | 2023 | 184 | 0.380 |
Why?
| | Health Services | 1 | 2012 | 108 | 0.380 |
Why?
| | Social Class | 4 | 2022 | 215 | 0.380 |
Why?
| | Surgical Procedures, Operative | 2 | 2012 | 211 | 0.370 |
Why?
| | Physician Self-Referral | 1 | 2010 | 1 | 0.370 |
Why?
| | Intestinal Perforation | 3 | 2016 | 37 | 0.360 |
Why?
| | Biomedical Research | 2 | 2020 | 596 | 0.360 |
Why?
| | Physicians | 1 | 2018 | 781 | 0.350 |
Why?
| | Waiting Lists | 1 | 2011 | 225 | 0.350 |
Why?
| | Financing, Personal | 2 | 2019 | 27 | 0.350 |
Why?
| | Recovery of Function | 1 | 2013 | 590 | 0.340 |
Why?
| | Gastrointestinal Hemorrhage | 3 | 2016 | 102 | 0.340 |
Why?
| | Astrocytoma | 1 | 2010 | 110 | 0.340 |
Why?
| | Radiation Oncology | 1 | 2010 | 76 | 0.340 |
Why?
| | Costs and Cost Analysis | 2 | 2022 | 200 | 0.340 |
Why?
| | Data Collection | 3 | 2014 | 641 | 0.340 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2019 | 610 | 0.330 |
Why?
| | Surveys and Questionnaires | 11 | 2018 | 4663 | 0.330 |
Why?
| | Administration, Oral | 2 | 2023 | 744 | 0.330 |
Why?
| | Propensity Score | 1 | 2010 | 237 | 0.330 |
Why?
| | Dentists | 1 | 2008 | 20 | 0.320 |
Why?
| | Life Expectancy | 1 | 2008 | 51 | 0.320 |
Why?
| | Persuasive Communication | 1 | 2008 | 13 | 0.320 |
Why?
| | Dental Care | 1 | 2008 | 28 | 0.320 |
Why?
| | HIV Infections | 2 | 2022 | 2447 | 0.320 |
Why?
| | Oropharyngeal Neoplasms | 2 | 2018 | 51 | 0.310 |
Why?
| | Multivariate Analysis | 9 | 2019 | 1458 | 0.310 |
Why?
| | Odds Ratio | 9 | 2014 | 981 | 0.300 |
Why?
| | Communication | 2 | 2019 | 759 | 0.300 |
Why?
| | Models, Econometric | 5 | 2017 | 34 | 0.290 |
Why?
| | Pneumonectomy | 1 | 2008 | 126 | 0.290 |
Why?
| | Depression | 4 | 2021 | 1137 | 0.290 |
Why?
| | Patient Education as Topic | 1 | 2011 | 687 | 0.290 |
Why?
| | Likelihood Functions | 5 | 2021 | 134 | 0.270 |
Why?
| | Confidence Intervals | 4 | 2013 | 314 | 0.270 |
Why?
| | Time Factors | 11 | 2013 | 6240 | 0.270 |
Why?
| | Education, Medical, Graduate | 1 | 2010 | 383 | 0.270 |
Why?
| | Quality-Adjusted Life Years | 4 | 2017 | 103 | 0.270 |
Why?
| | Online Systems | 1 | 2005 | 25 | 0.260 |
Why?
| | Anxiety | 3 | 2021 | 857 | 0.260 |
Why?
| | Myocardial Infarction | 3 | 2023 | 960 | 0.260 |
Why?
| | Colonic Diseases | 2 | 2016 | 25 | 0.260 |
Why?
| | Referral and Consultation | 1 | 2010 | 640 | 0.260 |
Why?
| | Cross Infection | 2 | 2017 | 204 | 0.250 |
Why?
| | Cohort Studies | 7 | 2023 | 5051 | 0.250 |
Why?
| | Disability Evaluation | 1 | 2007 | 274 | 0.250 |
Why?
| | Cost Savings | 2 | 2018 | 76 | 0.250 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2014 | 2159 | 0.250 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2011 | 539 | 0.240 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 2 | 2017 | 193 | 0.240 |
Why?
| | Health Services Needs and Demand | 3 | 2017 | 249 | 0.240 |
Why?
| | Needs Assessment | 2 | 2024 | 320 | 0.240 |
Why?
| | Models, Statistical | 4 | 2017 | 627 | 0.240 |
Why?
| | Substance-Related Disorders | 3 | 1997 | 947 | 0.230 |
Why?
| | Physician-Patient Relations | 1 | 2008 | 474 | 0.230 |
Why?
| | Hospitals, Public | 1 | 2023 | 23 | 0.220 |
Why?
| | Head and Neck Neoplasms | 2 | 2019 | 478 | 0.220 |
Why?
| | Forecasting | 5 | 2016 | 335 | 0.220 |
Why?
| | Colorado | 2 | 2023 | 4124 | 0.220 |
Why?
| | Staphylococcal Infections | 2 | 2017 | 344 | 0.220 |
Why?
| | Intensive Care Units | 2 | 2017 | 630 | 0.210 |
Why?
| | Economics, Medical | 1 | 2022 | 4 | 0.210 |
Why?
| | Carcinoma | 2 | 2017 | 201 | 0.210 |
Why?
| | Hormones | 1 | 2023 | 131 | 0.210 |
Why?
| | Age Distribution | 4 | 2020 | 340 | 0.210 |
Why?
| | Risk Assessment | 6 | 2022 | 3022 | 0.210 |
Why?
| | Analgesics, Opioid | 2 | 2021 | 793 | 0.210 |
Why?
| | Colonic Polyps | 2 | 2014 | 73 | 0.210 |
Why?
| | Proportional Hazards Models | 5 | 2019 | 1105 | 0.210 |
Why?
| | Health Behavior | 2 | 2019 | 709 | 0.210 |
Why?
| | Incidence | 5 | 2022 | 2378 | 0.210 |
Why?
| | Food Supply | 1 | 2022 | 61 | 0.210 |
Why?
| | Bisexuality | 1 | 2022 | 16 | 0.210 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2021 | 878 | 0.210 |
Why?
| | Brain Neoplasms | 1 | 2010 | 1010 | 0.200 |
Why?
| | Hospital Charges | 3 | 2003 | 41 | 0.200 |
Why?
| | Treatment Outcome | 10 | 2019 | 9263 | 0.200 |
Why?
| | Smoking | 2 | 2019 | 1457 | 0.200 |
Why?
| | Hospitalization | 5 | 2016 | 1762 | 0.190 |
Why?
| | Decision Making | 2 | 2005 | 804 | 0.190 |
Why?
| | Evidence-Based Medicine | 2 | 2016 | 682 | 0.190 |
Why?
| | Internet | 1 | 2005 | 594 | 0.190 |
Why?
| | Homosexuality, Male | 1 | 2022 | 166 | 0.190 |
Why?
| | Sex Factors | 5 | 2022 | 1758 | 0.190 |
Why?
| | Retrospective Studies | 12 | 2021 | 12843 | 0.180 |
Why?
| | Kentucky | 1 | 2020 | 36 | 0.180 |
Why?
| | Delayed Diagnosis | 1 | 2020 | 75 | 0.180 |
Why?
| | Population Surveillance | 2 | 2022 | 406 | 0.180 |
Why?
| | California | 2 | 2018 | 366 | 0.180 |
Why?
| | Stress, Psychological | 2 | 2021 | 960 | 0.180 |
Why?
| | Benzodiazepines | 1 | 2021 | 116 | 0.180 |
Why?
| | Probability | 4 | 2023 | 296 | 0.180 |
Why?
| | Carrier State | 2 | 2017 | 57 | 0.170 |
Why?
| | Sample Size | 1 | 2000 | 132 | 0.170 |
Why?
| | Adolescent | 12 | 2020 | 18219 | 0.170 |
Why?
| | Regression Analysis | 5 | 2021 | 971 | 0.170 |
Why?
| | Ownership | 2 | 2010 | 82 | 0.170 |
Why?
| | Activities of Daily Living | 2 | 2010 | 348 | 0.170 |
Why?
| | Patient Selection | 3 | 2010 | 656 | 0.170 |
Why?
| | Language Development Disorders | 1 | 2019 | 37 | 0.170 |
Why?
| | Infection Control | 2 | 2017 | 135 | 0.170 |
Why?
| | Diabetes Mellitus | 3 | 2018 | 931 | 0.170 |
Why?
| | Los Angeles | 2 | 2015 | 55 | 0.160 |
Why?
| | Anthracyclines | 3 | 2023 | 41 | 0.160 |
Why?
| | National Cancer Institute (U.S.) | 3 | 2023 | 41 | 0.160 |
Why?
| | Infant, Newborn | 4 | 2020 | 5181 | 0.160 |
Why?
| | Cancer Pain | 1 | 2018 | 20 | 0.160 |
Why?
| | Taxoids | 3 | 2023 | 95 | 0.160 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2019 | 185 | 0.160 |
Why?
| | Carboplatin | 1 | 2018 | 140 | 0.160 |
Why?
| | Cetuximab | 1 | 2018 | 99 | 0.160 |
Why?
| | Hyperlipidemias | 1 | 2019 | 125 | 0.160 |
Why?
| | Ireland | 2 | 2016 | 25 | 0.160 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 381 | 0.150 |
Why?
| | Inpatients | 2 | 2012 | 379 | 0.150 |
Why?
| | Financing, Government | 1 | 2017 | 39 | 0.150 |
Why?
| | Unemployment | 2 | 2009 | 42 | 0.150 |
Why?
| | Patient Discharge | 1 | 2023 | 784 | 0.150 |
Why?
| | Managed Care Programs | 1 | 2018 | 134 | 0.150 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2015 | 100 | 0.150 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 50 | 0.150 |
Why?
| | Hypoglycemic Agents | 2 | 2018 | 1035 | 0.150 |
Why?
| | Public Health Practice | 1 | 2017 | 61 | 0.150 |
Why?
| | Cisplatin | 1 | 2018 | 272 | 0.140 |
Why?
| | Hospital Costs | 2 | 2011 | 107 | 0.140 |
Why?
| | Combined Modality Therapy | 4 | 2019 | 1144 | 0.140 |
Why?
| | Patient Rights | 2 | 2019 | 10 | 0.140 |
Why?
| | Psychiatric Department, Hospital | 1 | 1996 | 15 | 0.140 |
Why?
| | Heart Failure | 2 | 2023 | 1962 | 0.140 |
Why?
| | Language | 1 | 2019 | 262 | 0.140 |
Why?
| | Child Behavior | 1 | 1998 | 215 | 0.140 |
Why?
| | Clinical Competence | 2 | 2014 | 920 | 0.140 |
Why?
| | Drug Therapy | 1 | 2017 | 76 | 0.140 |
Why?
| | Sex Distribution | 3 | 2020 | 331 | 0.140 |
Why?
| | Self Efficacy | 1 | 2019 | 342 | 0.140 |
Why?
| | Lymph Nodes | 1 | 2019 | 430 | 0.140 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2016 | 47 | 0.130 |
Why?
| | Child, Preschool | 4 | 2020 | 9323 | 0.130 |
Why?
| | Smoking Cessation | 1 | 2019 | 357 | 0.130 |
Why?
| | Neonatal Abstinence Syndrome | 1 | 1996 | 15 | 0.130 |
Why?
| | Residence Characteristics | 2 | 2008 | 293 | 0.130 |
Why?
| | Patient Admission | 1 | 1997 | 175 | 0.130 |
Why?
| | Minority Groups | 1 | 2017 | 233 | 0.130 |
Why?
| | Follow-Up Studies | 6 | 2019 | 4507 | 0.130 |
Why?
| | Colorectal Surgery | 1 | 2015 | 22 | 0.130 |
Why?
| | Child Development | 1 | 2019 | 406 | 0.120 |
Why?
| | Infant | 3 | 2020 | 8133 | 0.120 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2015 | 141 | 0.120 |
Why?
| | Metformin | 1 | 2018 | 293 | 0.120 |
Why?
| | Mastectomy, Segmental | 3 | 2009 | 76 | 0.120 |
Why?
| | Autism Spectrum Disorder | 1 | 2019 | 325 | 0.120 |
Why?
| | Research Design | 3 | 2007 | 962 | 0.120 |
Why?
| | National Health Programs | 1 | 2014 | 20 | 0.120 |
Why?
| | Pilot Projects | 3 | 2021 | 1396 | 0.120 |
Why?
| | Systems Integration | 1 | 2013 | 38 | 0.110 |
Why?
| | Cerebrovascular Disorders | 1 | 2014 | 83 | 0.110 |
Why?
| | Intensive Care Units, Neonatal | 1 | 1996 | 181 | 0.110 |
Why?
| | Computer Simulation | 2 | 2023 | 903 | 0.110 |
Why?
| | Health Status Indicators | 1 | 2014 | 151 | 0.110 |
Why?
| | Prospective Studies | 3 | 2017 | 6391 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 3 | 2021 | 825 | 0.110 |
Why?
| | Helping Behavior | 1 | 2013 | 15 | 0.110 |
Why?
| | Quality of Health Care | 2 | 2008 | 580 | 0.110 |
Why?
| | Occupations | 1 | 2012 | 36 | 0.110 |
Why?
| | Medical Audit | 1 | 2013 | 74 | 0.110 |
Why?
| | Maryland | 3 | 1997 | 37 | 0.110 |
Why?
| | Child | 6 | 2020 | 18881 | 0.110 |
Why?
| | Mandatory Programs | 1 | 2012 | 16 | 0.110 |
Why?
| | Pregnancy, Unwanted | 1 | 2012 | 13 | 0.110 |
Why?
| | Insurance, Pharmaceutical Services | 1 | 2012 | 22 | 0.110 |
Why?
| | Life Tables | 2 | 2008 | 17 | 0.100 |
Why?
| | Cause of Death | 1 | 2014 | 369 | 0.100 |
Why?
| | Cost Control | 1 | 2012 | 40 | 0.100 |
Why?
| | Attitude to Health | 2 | 2019 | 403 | 0.100 |
Why?
| | Goals | 2 | 2023 | 161 | 0.100 |
Why?
| | Mental Disorders | 2 | 1997 | 899 | 0.100 |
Why?
| | Self Disclosure | 1 | 2011 | 59 | 0.100 |
Why?
| | Community Health Services | 1 | 2013 | 210 | 0.100 |
Why?
| | Contraception Behavior | 1 | 2012 | 80 | 0.100 |
Why?
| | Contraceptive Agents, Female | 1 | 2012 | 65 | 0.100 |
Why?
| | Sepsis | 1 | 2017 | 525 | 0.100 |
Why?
| | Educational Status | 1 | 2013 | 429 | 0.100 |
Why?
| | Retreatment | 1 | 2011 | 71 | 0.100 |
Why?
| | Mastectomy | 1 | 2011 | 105 | 0.100 |
Why?
| | Pregnancy Complications | 1 | 1996 | 446 | 0.100 |
Why?
| | Video Recording | 1 | 2011 | 151 | 0.100 |
Why?
| | Reproducibility of Results | 3 | 2010 | 2831 | 0.090 |
Why?
| | Economics, Nursing | 1 | 2010 | 1 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2014 | 502 | 0.090 |
Why?
| | Interinstitutional Relations | 1 | 2010 | 55 | 0.090 |
Why?
| | Stress, Physiological | 1 | 2013 | 409 | 0.090 |
Why?
| | Access to Information | 1 | 2010 | 51 | 0.090 |
Why?
| | Bone Marrow Transplantation | 1 | 2011 | 244 | 0.090 |
Why?
| | Consumer Behavior | 1 | 1990 | 64 | 0.090 |
Why?
| | Sentinel Surveillance | 1 | 2009 | 38 | 0.090 |
Why?
| | Standard of Care | 1 | 2010 | 63 | 0.090 |
Why?
| | Sex Characteristics | 2 | 2022 | 648 | 0.090 |
Why?
| | Occult Blood | 1 | 2009 | 27 | 0.090 |
Why?
| | Insurance Claim Reporting | 1 | 2009 | 23 | 0.090 |
Why?
| | Comparative Effectiveness Research | 1 | 2010 | 131 | 0.090 |
Why?
| | Women's Health | 2 | 2012 | 270 | 0.090 |
Why?
| | Ohio | 1 | 2009 | 143 | 0.090 |
Why?
| | Private Sector | 1 | 2009 | 51 | 0.080 |
Why?
| | Psychometrics | 1 | 2013 | 602 | 0.080 |
Why?
| | Exercise | 1 | 2019 | 1629 | 0.080 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2009 | 60 | 0.080 |
Why?
| | Linear Models | 1 | 2011 | 802 | 0.080 |
Why?
| | Physical Exertion | 1 | 2010 | 217 | 0.080 |
Why?
| | Bias | 1 | 2010 | 193 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2013 | 534 | 0.080 |
Why?
| | Home Nursing | 1 | 2008 | 27 | 0.080 |
Why?
| | Patient Satisfaction | 1 | 2013 | 595 | 0.080 |
Why?
| | Reimbursement Mechanisms | 1 | 2009 | 77 | 0.080 |
Why?
| | Education, Professional | 1 | 2008 | 18 | 0.080 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 327 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2010 | 536 | 0.080 |
Why?
| | Pain | 2 | 2010 | 719 | 0.070 |
Why?
| | Radiotherapy | 1 | 2008 | 186 | 0.070 |
Why?
| | Self Care | 1 | 2010 | 355 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 513 | 0.070 |
Why?
| | Leukemia | 1 | 2008 | 208 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2010 | 476 | 0.070 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2006 | 107 | 0.070 |
Why?
| | Lung Diseases | 1 | 2012 | 693 | 0.070 |
Why?
| | Charities | 1 | 2005 | 9 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 1114 | 0.070 |
Why?
| | Case-Control Studies | 2 | 2019 | 3099 | 0.060 |
Why?
| | Empirical Research | 1 | 2005 | 23 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1233 | 0.060 |
Why?
| | Hospice Care | 1 | 2007 | 181 | 0.060 |
Why?
| | Diagnosis-Related Groups | 1 | 2003 | 29 | 0.060 |
Why?
| | Pennsylvania | 1 | 2023 | 97 | 0.060 |
Why?
| | Resource Allocation | 1 | 2003 | 38 | 0.060 |
Why?
| | Florida | 2 | 2014 | 76 | 0.060 |
Why?
| | Prevalence | 1 | 2010 | 2300 | 0.060 |
Why?
| | Pandemics | 2 | 2022 | 1355 | 0.060 |
Why?
| | Health Surveys | 2 | 2007 | 443 | 0.060 |
Why?
| | Causality | 1 | 2023 | 110 | 0.050 |
Why?
| | Interviews as Topic | 1 | 2005 | 592 | 0.050 |
Why?
| | Women, Working | 1 | 2002 | 9 | 0.050 |
Why?
| | Selection Bias | 1 | 2002 | 34 | 0.050 |
Why?
| | Markov Chains | 2 | 2017 | 118 | 0.050 |
Why?
| | Motor Activity | 1 | 2007 | 644 | 0.050 |
Why?
| | Sampling Studies | 1 | 2002 | 91 | 0.050 |
Why?
| | Mastectomy, Radical | 1 | 2001 | 2 | 0.050 |
Why?
| | Pancreatic Neoplasms | 1 | 2008 | 716 | 0.050 |
Why?
| | Palliative Care | 1 | 2007 | 623 | 0.050 |
Why?
| | Arrhythmias, Cardiac | 1 | 2023 | 273 | 0.050 |
Why?
| | Family Characteristics | 1 | 2002 | 155 | 0.050 |
Why?
| | Normal Distribution | 1 | 2000 | 23 | 0.050 |
Why?
| | Drug Evaluation | 1 | 2000 | 79 | 0.050 |
Why?
| | Diffusion of Innovation | 1 | 2001 | 93 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2008 | 2634 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2004 | 957 | 0.040 |
Why?
| | Nursing Research | 1 | 2000 | 38 | 0.040 |
Why?
| | Presenteeism | 1 | 2019 | 5 | 0.040 |
Why?
| | Etidronic Acid | 1 | 1998 | 3 | 0.040 |
Why?
| | Alendronate | 1 | 1998 | 7 | 0.040 |
Why?
| | Informed Consent | 1 | 2000 | 162 | 0.040 |
Why?
| | Federal Government | 1 | 2018 | 26 | 0.040 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 1998 | 38 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2021 | 375 | 0.040 |
Why?
| | Lymph Node Excision | 1 | 2019 | 146 | 0.040 |
Why?
| | Lymphatic Metastasis | 1 | 2019 | 286 | 0.040 |
Why?
| | Controlled Before-After Studies | 1 | 2017 | 15 | 0.040 |
Why?
| | Smoking Prevention | 1 | 1998 | 150 | 0.040 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 116 | 0.040 |
Why?
| | Tennessee | 1 | 2017 | 41 | 0.040 |
Why?
| | Ecosystem | 1 | 2022 | 546 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2002 | 457 | 0.040 |
Why?
| | Spinal Fractures | 1 | 1998 | 81 | 0.040 |
Why?
| | Puberty | 1 | 1998 | 143 | 0.040 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 1997 | 35 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2018 | 199 | 0.040 |
Why?
| | Patient Isolation | 1 | 2017 | 18 | 0.040 |
Why?
| | Catheter-Related Infections | 1 | 2017 | 59 | 0.040 |
Why?
| | Biopsy, Needle | 1 | 2017 | 181 | 0.040 |
Why?
| | Patient Dropouts | 1 | 1997 | 66 | 0.040 |
Why?
| | Bacteriological Techniques | 1 | 2017 | 65 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2017 | 48 | 0.040 |
Why?
| | Utilization Review | 1 | 1996 | 36 | 0.040 |
Why?
| | Arizona | 1 | 1996 | 68 | 0.040 |
Why?
| | Schools | 1 | 2000 | 403 | 0.040 |
Why?
| | Health Policy | 1 | 2019 | 333 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 723 | 0.030 |
Why?
| | Dyslipidemias | 1 | 2018 | 159 | 0.030 |
Why?
| | Anticholesteremic Agents | 1 | 2018 | 130 | 0.030 |
Why?
| | Hospitals, Community | 1 | 1996 | 48 | 0.030 |
Why?
| | Obstetric Labor, Premature | 1 | 1996 | 33 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 453 | 0.030 |
Why?
| | Health Resources | 2 | 2009 | 129 | 0.030 |
Why?
| | Antihypertensive Agents | 1 | 2018 | 434 | 0.030 |
Why?
| | Protoporphyrins | 1 | 1993 | 16 | 0.030 |
Why?
| | Acute Disease | 1 | 1996 | 916 | 0.030 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 427 | 0.030 |
Why?
| | Lead | 1 | 1993 | 46 | 0.030 |
Why?
| | Learning Curve | 1 | 2014 | 69 | 0.030 |
Why?
| | Sensitivity and Specificity | 3 | 2009 | 1740 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2017 | 1657 | 0.030 |
Why?
| | Societies, Medical | 1 | 2016 | 684 | 0.030 |
Why?
| | Calcium | 1 | 1998 | 1125 | 0.030 |
Why?
| | Community Participation | 1 | 2013 | 120 | 0.030 |
Why?
| | General Surgery | 1 | 2014 | 133 | 0.030 |
Why?
| | Pregnancy | 2 | 2012 | 5653 | 0.030 |
Why?
| | Stroke | 1 | 2020 | 1021 | 0.030 |
Why?
| | Gastroenterology | 1 | 2014 | 159 | 0.030 |
Why?
| | Risk | 1 | 2014 | 842 | 0.030 |
Why?
| | Cooperative Behavior | 1 | 2013 | 391 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3390 | 0.020 |
Why?
| | Contraception | 1 | 2012 | 117 | 0.020 |
Why?
| | Hepatitis B | 1 | 1991 | 52 | 0.020 |
Why?
| | Work Capacity Evaluation | 1 | 2010 | 13 | 0.020 |
Why?
| | Leadership | 1 | 2013 | 306 | 0.020 |
Why?
| | Budgets | 1 | 2009 | 14 | 0.020 |
Why?
| | Sigmoidoscopy | 1 | 2009 | 10 | 0.020 |
Why?
| | Hypertension | 1 | 2018 | 1179 | 0.020 |
Why?
| | Task Performance and Analysis | 1 | 2010 | 161 | 0.020 |
Why?
| | Ambulatory Care | 1 | 2013 | 478 | 0.020 |
Why?
| | Meta-Analysis as Topic | 1 | 2009 | 165 | 0.020 |
Why?
| | Prostatectomy | 1 | 2009 | 97 | 0.020 |
Why?
| | Occupational Exposure | 1 | 1991 | 272 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 456 | 0.020 |
Why?
| | Psychology | 1 | 2008 | 83 | 0.020 |
Why?
| | Demography | 1 | 2008 | 269 | 0.020 |
Why?
| | Mortality | 1 | 2008 | 291 | 0.020 |
Why?
| | Lifting | 1 | 2006 | 5 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2006 | 71 | 0.020 |
Why?
| | Illinois | 1 | 2006 | 36 | 0.020 |
Why?
| | Telephone | 1 | 2007 | 149 | 0.020 |
Why?
| | Body Weight | 1 | 1990 | 901 | 0.020 |
Why?
| | Patient Compliance | 1 | 2009 | 528 | 0.020 |
Why?
| | Prejudice | 1 | 2006 | 57 | 0.020 |
Why?
| | Burnout, Professional | 1 | 2010 | 320 | 0.020 |
Why?
| | Myocardial Revascularization | 1 | 2003 | 68 | 0.010 |
Why?
| | Vaccination | 1 | 1991 | 1215 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 392 | 0.010 |
Why?
| | Behavior | 1 | 2002 | 92 | 0.010 |
Why?
| | Episode of Care | 1 | 2001 | 5 | 0.010 |
Why?
| | Decision Trees | 1 | 2001 | 82 | 0.010 |
Why?
| | Drug Prescriptions | 1 | 2002 | 241 | 0.010 |
Why?
| | Cardiac Catheterization | 1 | 2003 | 539 | 0.010 |
Why?
| | Reoperation | 1 | 2001 | 535 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2002 | 924 | 0.010 |
Why?
| | Estrogens | 1 | 1998 | 326 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 1998 | 965 | 0.010 |
Why?
| | Estradiol | 1 | 1998 | 465 | 0.010 |
Why?
| | Lead Poisoning | 1 | 1993 | 17 | 0.010 |
Why?
| | ROC Curve | 1 | 1993 | 460 | 0.010 |
Why?
| | Reference Values | 1 | 1993 | 751 | 0.010 |
Why?
| | Program Evaluation | 1 | 1991 | 830 | 0.000 |
Why?
|
|
Bradley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|